New Diagnostic Tools and Biomarkers in Oncological Diseases 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 1027
Special Issue Editor
Interests: biological fluids; cancer; cancer biomarkers; cfDI; cfDNA; cfNA; copy number variation; ctDNA; ddPCR; disease-free survival; epigenetic; epigenetic sequencing; exosome; extracellular vesicle; genotyping; liquid biopsy; miRNA; mRNA; mutation; ncRNA; next- generation sequencing; overall survival; progression-free survival; recurrence-free survival; whole-exome sequencing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Personalized medicine has become a new paradigm for the treatment of a variety of diseases.
New diagnostic tools and biomarkers have transformed the understanding of oncologic diseases over the past decade and have helped to provide patients with the best screening, diagnosis, prognosis, therapy, and follow-up.
For example, liquid biopsy has great potential for precision medicine, especially in solid tumors, liquid biopsy is suitable for screening, diagnosis, prognosis, predictive value, and disease monitoring. In addition, other small molecules such as miRNA, ncRNA, and exosomes can be used for tumor diagnosis, prognosis, and therapy. Also, the new technologies and the high throughput facilities have substantially increased the sensitivity and rapidity of the oncological tests and other potential improvements are ongoing.
This Special Issue aims to publish the recent advances in the new diagnostic tools and biomarkers for oncological diseases. Original research and review articles are welcome in this Special Issue.
More published papers can be found in the closed special issue: New Diagnostic Tools and Biomarkers in Oncological Diseases.
Dr. Bruna Scaggiante
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncologic diseases
- biomarkers
- liquid biopsy
- miRNA
- ncRNA
- exosomes
